Cargando…

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease

Background and Objectives: Parkinson’s disease (PD) is a clinically heterogeneous disorder with poorly understood pathological contributing factors. Depression presents one of the most frequent non-motor PD manifestations, and several genetic polymorphisms have been suggested that could affect the d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelopoulou, Efthalia, Bougea, Anastasia, Paudel, Yam Nath, Georgakopoulou, Vasiliki Epameinondas, Papageorgiou, Sokratis G., Piperi, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301401/ https://www.ncbi.nlm.nih.gov/pubmed/37374342 http://dx.doi.org/10.3390/medicina59061138

Ejemplares similares

Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches
por: Degirmenci, Yildiz, et al.
Publicado: (2023)

Psychosis in Parkinson’s Disease: A Lesson from Genetics
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Emerging Pathogenic and Prognostic Significance of Paired Box 3 (PAX3) Protein in Adult Gliomas
por: Angelopoulou, Efthalia, et al.
Publicado: (2019)

New‑onset non‑motor symptoms in patients with Parkinson's disease and post‑COVID‑19 syndrome: A prospective cross‑sectional study
por: Bougea, Anastasia, et al.
Publicado: (2023)

Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Flotillin: A Promising Biomarker for Alzheimer’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders
por: Mishra, Awanish, et al.
Publicado: (2021)

Characteristics and outcomes of elderly patients with Parkinson's disease hospitalized due to COVID‑19‑associated pneumonia
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
por: Paudel, Yam Nath, et al.
Publicado: (2020)

HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities
por: Paudel, Yam Nath, et al.
Publicado: (2020)

From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
por: Paudel, Yam Nath, et al.
Publicado: (2020)

New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders
por: Villa, Chiara, et al.
Publicado: (2022)

Migraine, Tension-Type Headache and Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Prosopagnosia, Other Specific Cognitive Deficits, and Behavioral Symptoms: Comparison between Right Temporal and Behavioral Variant of Frontotemporal Dementia
por: Koros, Christos, et al.
Publicado: (2022)

Predictors of COVID‑19‑associated mortality among hospitalized elderly patients with dementia
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Can sars-cov-2 infection exacerbate Alzheimer’s disease? A systematic review
por: Chiara, Villa, et al.
Publicado: (2021)

Ambiental Factors in Parkinson’s Disease Progression: A Systematic Review
por: Bougea, Anastasia, et al.
Publicado: (2023)

Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Recent Developments in Diagnosis of Epilepsy: Scope of MicroRNA and Technological Advancements
por: Bandopadhyay, Ritam, et al.
Publicado: (2021)

Outcomes in meningitis‑ventriculitis treated with intravenous or intrathecal plus intravenous colistin: A meta‑analysis
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

The Landscape of Monogenic Parkinson’s Disease in Populations of Non-European Ancestry: A Narrative Review
por: Koros, Christos, et al.
Publicado: (2023)

Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson’s Disease and Asymptomatic Carriers of Related Genes: A Brief Report
por: Koros, Christos, et al.
Publicado: (2023)

Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study
por: Koros, Christos, et al.
Publicado: (2023)

Role of miR‑200 family in brain metastases: A systematic review
por: Fotakopoulos, George, et al.
Publicado: (2023)

Rhythmic cueing, dance, resistance training, and Parkinson's disease: A systematic review and meta-analysis
por: Karpodini, Claire Chrysanthi, et al.
Publicado: (2022)

How Telemedicine Can Improve the Quality of Care for Patients with Alzheimer’s Disease and Related Dementias? A Narrative Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Pathophysiology of cervical myelopathy (Review)
por: Fotakopoulos, George, et al.
Publicado: (2023)

Biomarkers in Alzheimer Disease and Other Dementias: What’s Next into Pathophysiology to Support Clinical Practice and Drug Development
por: Bougea, Anastasia
Publicado: (2022)

Editorial: Body fluid biomarkers in neurodegenerative studies: Novel insights into pathophysiology to support clinical practice and drug development
por: Bougea, Anastasia, et al.
Publicado: (2023)

Silent Pauses and Speech Indices as Biomarkers for Primary Progressive Aphasia
por: Potagas, Constantin, et al.
Publicado: (2022)

Pulmonary function testing in patients with liver cirrhosis (Review)
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Phenomenology and management of cognitive and behavioral disorders in Parkinson's disease. Rise and logic of dementia in Parkinson's disease
por: Potagas, Constantin, et al.
Publicado: (2006)

Validation of NoSAS score for the screening of obstructive sleep apnea
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

APOE Allele Frequency in Southern Greece: Exploring the Role of Geographical Gradient in the Greek Population
por: Papastefanopoulou, Vasiliki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_av6ff230n49r5430drulvgguo7